I would like to thank Conal for his never-ending willingness to help and provide regulatory guidance. May it be an IRB question or FDA regulation/policy, he is always happy to assist. In times when our IRB is swamped with urgent submissions of COVID-19 trials, Conal still manages to make himself available and lend a helping hand. Thank you for everything you do! - Alice Szydlowska, MBA